Financial Ratios Becton, Dickinson and Company
Equities
BDX
US0758871091
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 143.47 USD | -0.69% |
|
-3.99% | -26.07% |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.9 | 3.09 | 3.25 | 3.23 | 4.06 | |||||
Return on Total Capital | 5.02 | 3.94 | 4.09 | 3.99 | 4.96 | |||||
Return On Equity % | 8.82 | 6.68 | 5.99 | 6.6 | 6.54 | |||||
Return on Common Equity | 8.44 | 6.31 | 5.76 | 6.6 | 6.54 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 47.29 | 45.65 | 45.55 | 45.22 | 46.98 | |||||
SG&A Margin | 24.04 | 25.04 | 24.87 | 24.39 | 24.55 | |||||
EBITDA Margin % | 27.86 | 25.78 | 26.01 | 25.4 | 28.04 | |||||
EBITA Margin % | 23.57 | 21.55 | 21.76 | 21.35 | 24.03 | |||||
EBIT Margin % | 16.64 | 13.97 | 14.2 | 14.07 | 16.77 | |||||
Income From Continuing Operations Margin % | 10.33 | 8.66 | 7.9 | 8.45 | 7.68 | |||||
Net Income Margin % | 10.33 | 9.43 | 7.66 | 8.45 | 7.68 | |||||
Net Avail. For Common Margin % | 9.89 | 8.19 | 7.59 | 8.45 | 7.68 | |||||
Normalized Net Income Margin | 9.06 | 7.22 | 7.56 | 7.68 | 8.78 | |||||
Levered Free Cash Flow Margin | 18.03 | 9.67 | 14.74 | 17.16 | 16.23 | |||||
Unlevered Free Cash Flow Margin | 19.48 | 10.99 | 16.2 | 18.79 | 17.98 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.38 | 0.35 | 0.37 | 0.37 | 0.39 | |||||
Fixed Assets Turnover | 3.07 | 2.92 | 2.86 | 2.73 | 2.8 | |||||
Receivables Turnover (Average Receivables) | 8.27 | 8.31 | 8.2 | 7.25 | 7.25 | |||||
Inventory Turnover (Average Inventory) | 3.81 | 3.44 | 3.25 | 3.11 | 2.99 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.33 | 1.04 | 1.31 | 1.17 | 1.11 | |||||
Quick Ratio | 0.72 | 0.41 | 0.6 | 0.58 | 0.44 | |||||
Operating Cash Flow to Current Liabilities | 0.7 | 0.35 | 0.45 | 0.42 | 0.41 | |||||
Days Sales Outstanding (Average Receivables) | 44.12 | 43.92 | 44.51 | 50.49 | 50.36 | |||||
Days Outstanding Inventory (Average Inventory) | 95.92 | 106.18 | 112.4 | 117.82 | 121.95 | |||||
Average Days Payable Outstanding | 53.22 | 58.44 | 57.52 | 55.69 | 60.73 | |||||
Cash Conversion Cycle (Average Days) | 86.82 | 91.66 | 99.4 | 112.62 | 111.58 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 76.36 | 65.53 | 63.61 | 80.8 | 78.85 | |||||
Total Debt / Total Capital | 43.3 | 39.59 | 38.88 | 44.69 | 44.09 | |||||
LT Debt/Equity | 73.72 | 56.44 | 58.74 | 71.87 | 72.17 | |||||
Long-Term Debt / Total Capital | 41.8 | 34.1 | 35.9 | 39.75 | 40.35 | |||||
Total Liabilities / Total Assets | 56.04 | 52.24 | 51.13 | 54.81 | 54.11 | |||||
EBIT / Interest Expense | 7.18 | 6.62 | 6.09 | 5.38 | 5.97 | |||||
EBITDA / Interest Expense | 12.31 | 12.57 | 11.47 | 10.07 | 10.31 | |||||
(EBITDA - Capex) / Interest Expense | 9.69 | 10.13 | 9.54 | 8.7 | 9.07 | |||||
Total Debt / EBITDA | 3.13 | 3.31 | 3.17 | 3.94 | 3.17 | |||||
Net Debt / EBITDA | 2.73 | 3.11 | 2.89 | 3.53 | 3.07 | |||||
Total Debt / (EBITDA - Capex) | 3.98 | 4.11 | 3.81 | 4.56 | 3.6 | |||||
Net Debt / (EBITDA - Capex) | 3.47 | 3.86 | 3.48 | 4.09 | 3.48 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 18.29 | -1.36 | 2.66 | 4.16 | 8.24 | |||||
Gross Profit, 1 Yr. Growth % | 20.92 | -2.34 | 2.43 | 11.69 | 12.45 | |||||
EBITDA, 1 Yr. Growth % | 20.71 | -3.68 | 3.58 | 16.87 | 19.31 | |||||
EBITA, 1 Yr. Growth % | 22.23 | -3.72 | 3.69 | 20.91 | 21.62 | |||||
EBIT, 1 Yr. Growth % | 33.69 | -6.56 | 4.36 | 35.37 | 28.63 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 139.36 | 1.93 | -6.42 | 11.44 | -1.58 | |||||
Net Income, 1 Yr. Growth % | 139.36 | -14.96 | -16.58 | 14.89 | -1.58 | |||||
Normalized Net Income, 1 Yr. Growth % | 46.09 | -8.6 | 7.57 | 46.72 | 23.31 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 152.77 | 3.86 | -5.2 | 14.9 | -0.68 | |||||
Accounts Receivable, 1 Yr. Growth % | 4.13 | -6.77 | 15.65 | 19.69 | -1.29 | |||||
Inventory, 1 Yr. Growth % | 4.48 | 17.54 | 1.52 | 17.42 | 1.33 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 7.85 | 0.7 | 8.93 | 8.81 | 2.4 | |||||
Total Assets, 1 Yr. Growth % | -0.27 | -1.73 | -0.29 | 8.54 | -3.42 | |||||
Tangible Book Value, 1 Yr. Growth % | -4.84 | -10.27 | -16.97 | 18.79 | -7.53 | |||||
Common Equity, 1 Yr. Growth % | -0.37 | 6.78 | 2.04 | 0.36 | -1.93 | |||||
Cash From Operations, 1 Yr. Growth % | 31.31 | -39.94 | 13.48 | 27.07 | -9.69 | |||||
Capital Expenditures, 1 Yr. Growth % | 51.98 | -18.51 | -10.17 | -17.05 | 4.83 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 4.75 | -44.74 | 56.51 | 41.44 | 2.23 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 3.37 | -42.32 | 51.36 | 38.89 | 3.43 | |||||
Dividend Per Share, 1 Yr. Growth % | 5.06 | 4.82 | 4.6 | 4.4 | 9.47 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 8.22 | 8.35 | 0.63 | 3.41 | 6.18 | |||||
Gross Profit, 2 Yr. CAGR % | 7.49 | 9.99 | 0.02 | 3.36 | 12.07 | |||||
EBITDA, 2 Yr. CAGR % | 4.19 | 9.83 | -0.12 | 3.42 | 17.73 | |||||
EBITA, 2 Yr. CAGR % | 3.66 | 10.97 | -0.08 | 3.86 | 20.82 | |||||
EBIT, 2 Yr. CAGR % | 6.97 | 17.23 | -1.25 | 5.24 | 31.12 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 30.26 | 115.52 | -2.33 | 2.12 | 4.72 | |||||
Net Income, 2 Yr. CAGR % | 30.26 | 42.67 | -15.78 | -2.1 | 6.34 | |||||
Normalized Net Income, 2 Yr. CAGR % | 11.33 | 24.4 | -0.84 | 8.51 | 33.44 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 31.86 | 148.67 | -0.78 | 4.37 | 6.83 | |||||
Accounts Receivable, 2 Yr. CAGR % | 3.19 | -4.41 | 3.84 | 17.66 | 8.7 | |||||
Inventory, 2 Yr. CAGR % | 5.42 | 8.41 | 9.23 | 9.18 | 9.07 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 9.93 | 1.2 | 4.73 | 8.87 | 5.56 | |||||
Total Assets, 2 Yr. CAGR % | 2.01 | -1 | -1.01 | 4.03 | 2.38 | |||||
Tangible Book Value, 2 Yr. CAGR % | -13.22 | -7.68 | -13.68 | -0.68 | 4.81 | |||||
Common Equity, 2 Yr. CAGR % | 5.98 | 3.14 | 4.38 | 1.2 | -0.79 | |||||
Cash From Operations, 2 Yr. CAGR % | 18.13 | -11.02 | -19.8 | 20.08 | 7.12 | |||||
Capital Expenditures, 2 Yr. CAGR % | 13.42 | 12.48 | -14.44 | -13.68 | -6.75 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 12.42 | -23.4 | -7 | 39.47 | 19.83 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 9.52 | -22.36 | -6.57 | 36.72 | 19.49 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.82 | 4.94 | 4.71 | 4.5 | 6.9 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.2 | 2.96 | 6.42 | 1.79 | 4.99 | |||||
Gross Profit, 3 Yr. CAGR % | 7.05 | 1.29 | 7.41 | 1.14 | 6.3 | |||||
EBITDA, 3 Yr. CAGR % | 5.9 | -2.18 | 7.71 | 0.49 | 8.51 | |||||
EBITA, 3 Yr. CAGR % | 5.82 | -2.9 | 8.49 | 0.67 | 9.53 | |||||
EBIT, 3 Yr. CAGR % | 6.72 | -3.62 | 12.78 | 0.22 | 12.62 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 88.77 | 9.86 | 63.2 | 2.06 | 0.87 | |||||
Net Income, 3 Yr. CAGR % | 88.77 | 13 | 19.3 | -6.59 | -1.93 | |||||
Normalized Net Income, 3 Yr. CAGR % | 10.86 | -2.73 | 18.52 | 1.34 | 13.34 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 125.17 | 10.94 | 80.31 | 4.2 | 2.66 | |||||
Accounts Receivable, 3 Yr. CAGR % | 2.5 | -2.24 | 1.86 | 8.88 | 10.97 | |||||
Inventory, 3 Yr. CAGR % | 5.35 | 7.72 | 6.07 | 11.9 | 6.5 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.36 | 4.69 | 3.71 | 6.07 | 6.67 | |||||
Total Assets, 3 Yr. CAGR % | -0.02 | 0.75 | -0.77 | 2.07 | 1.48 | |||||
Tangible Book Value, 3 Yr. CAGR % | -11.94 | -12.3 | -10.89 | -3.99 | -3.02 | |||||
Common Equity, 3 Yr. CAGR % | 4.09 | 6.25 | 2.77 | 3.03 | 0.14 | |||||
Cash From Operations, 3 Yr. CAGR % | 17.49 | -5.96 | -5.1 | -6.5 | 9.2 | |||||
Capital Expenditures, 3 Yr. CAGR % | 11.21 | 0.55 | 4.36 | -15.32 | -7.91 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 15.63 | -14.2 | -2.8 | 1.59 | 25.8 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 12.06 | -14.25 | -3.01 | 1.79 | 24.63 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.44 | 4.15 | 4.83 | 4.6 | 6.13 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 10.16 | 9.31 | 3.92 | 3.14 | 6.32 | |||||
Gross Profit, 5 Yr. CAGR % | 9.83 | 7.63 | 2.48 | 1.94 | 7.58 | |||||
EBITDA, 5 Yr. CAGR % | 11.51 | 7.87 | 1.19 | -0.27 | 8.71 | |||||
EBITA, 5 Yr. CAGR % | 11.98 | 7.78 | 0.92 | -0.61 | 9.71 | |||||
EBIT, 5 Yr. CAGR % | 9.32 | 3.28 | -0.15 | -0.72 | 13.81 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16.47 | 8.25 | 37.53 | 6.7 | 36.66 | |||||
Net Income, 5 Yr. CAGR % | 16.47 | 10.09 | 36.69 | 6.7 | 13.93 | |||||
Normalized Net Income, 5 Yr. CAGR % | 10.26 | 4.05 | 1.7 | 0.94 | 16.86 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 8.82 | 3.18 | 53.42 | 8.26 | 46.24 | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.99 | 4.67 | 1.79 | 5.28 | 4.54 | |||||
Inventory, 5 Yr. CAGR % | 10.76 | 12.14 | 5.95 | 8.3 | 7.26 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 11.88 | 6.96 | 5.65 | 6.34 | 4.45 | |||||
Total Assets, 5 Yr. CAGR % | 16.05 | 7 | -0.42 | 2.05 | 0.48 | |||||
Tangible Book Value, 5 Yr. CAGR % | 16.48 | 86.96 | -12.67 | -7.83 | -4.91 | |||||
Common Equity, 5 Yr. CAGR % | 25.41 | 14.32 | 4.21 | 4.2 | 1.33 | |||||
Cash From Operations, 5 Yr. CAGR % | 12.67 | 1.66 | 0.85 | 2.66 | -0.39 | |||||
Capital Expenditures, 5 Yr. CAGR % | 12.18 | 6 | -0.47 | -5.4 | -0.24 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 17.98 | 1.27 | 3.88 | 3.69 | 2.65 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 16.47 | 0.34 | 2.29 | 2.89 | 2.68 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.69 | 3.57 | 3.94 | 4.29 | 5.65 |
- Stock Market
- Equities
- BDX Stock
- Financials Becton, Dickinson and Company
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















